Press Releases

FOXBOROUGH, Mass., July 12, 2019 /PRNewswire/ -- Viant, a leading global services provider to the medical device industry, announced today that its board of directors has appointed Alton E. Shader to chief executive officer, effective July 15, 2019.  Mr. Shader, who brings more than 20 years of medical device leadership experience to Via

BALTIMORE, July 12, 2019 /PRNewswire/ -- Real Time Medical Systems (Real Time), the leading healthcare interventional analytics software company for long-term care facilities, hospitals, ACOs, and payers, has seen a 150% growth in sales since the beginning of 2018 as demand increases for an intuitive Patient-Driven Payment Model (PDPM) solution amongst SNFs nationw

SAN DIEGO, July 12, 2019 /PRNewswire/ -- Seqster, the leading consumer-mediated health data interoperability platform, today announced the expansion of their partnership with Boston University ("BU") for the use of Seqster Research Portal ("SRP™") as the solution for streamlined patient recruitment and consent at the Alzheimer's Associa

MELBOURNE, Fla., July 12, 2019 /PRNewswire/ -- This coming weekend, Sun Nuclear Corporation will present comprehensive Quality Management solutions for Radiation Therapy, Patient Alignment, and Diagnostic Imaging at the

INDIANAPOLIS, July 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced the upcoming presentation of data highlighting inconsistent and sub-optimal treatment patterns that people living with migraine experience across the U.S. healthcare landscape, specifically related to where they receive care.1 These data are from the OVERCOME (O

BOSTON, July 12, 2019 /PRNewswire/ -- Quincy Miller, vice chair and president of Eastern Bank, has been elected to the board of directors of Blue Cross Blue Shield of Massachusetts.

STOCKHOLM, July 12, 2019 /PRNewswire/ -- During 14–17 July, RaySearch will exhibit its latest advances at the 61st AAPM Annual Meeting in San Antonio, US. The company will demonstrate RayCare® 3A*, the latest release of the groundbreaking oncology information system, and RayStation® 9A*, the new release of the innovative

WINSTON-SALEM, N.C., July 12, 2019 /PRNewswire/ -- Hundreds of high school students from around the world – including Rwanda, the United Arab Emirates, Australia, Korea, Italy, Bolivia and

CAMBRIDGE, Mass., July 12, 2019 /PRNewswire/ -- EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with dementia with Lewy bodies (DLB). The primary objective of the study is to determine whether neflamapimod, a b

INDIANAPOLIS, July 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the presentation of post-hoc analyses showing improvements in daily functioning and reductions in disability in patients with chronic and episodic migraine treated with Emgality® (galcanezumab-gnlm) compared to placebo.1 The analyses are base